Enbrel-Humira-Remicade-Orencia-Kineret-Simponi-Cimzia-Actemra-Stelara
_____________________________
OptumRx
Patients Name:
Page 2 of 2
Fax # 1-800-853-3844
_____________________________
__________
Patients ID#:
DOB:
OptumRx Specialty Prior Authorization (continued)
Document the patient’s diagnosis: _____________________________ ICD-9 Code _____________________________
Please Document all that applies to the Patient
Has the patient been evaluated for tuberculosis and treated accordingly?
Yes
No
Document date of last PPD test:
Negative
Positive
For Diagnosis of Rheumatoid Arthritis or Ulcerative Colitis: Does the Patient exhibit symptoms of MODERATE to SEVERE?
Yes
No
For Diagnosis of Psoriasis: Does the patient have failure, intolerance or contraindication to: (Please check all that apply)
Ultraviolet Light B (UVB),
Pulsed Dye Laser,
Photochemotherapy,
Psoralen and
exposure to Ultraviolet light a (PUVA)
Yes
No
For Diagnosis of Crohn’s Disease: Does the patient exhibit symptoms of MODERATE to SEVERE?
Has induction dose been prescribed?
Yes
No
(if NO document reason why it has not been prescribed)
Document if the patient has tried, failed or had contraindication
Methotrexate
6- mercaptopurine (Purnethol)
Imuran (azathioprine)
NSAIDs (e.g. Ibuprofen)
Cyclosporine (Sandimmune, Neoral)
6- thioguanine
Gold compounds (Myochrisine, Ridura, Aurolate, and Solganal)
Acitretin (soriatane)
Plaquenil (hydroxychloroquine)
Hydroxyurea (hydrea)
Arava (leflonomide)
Mycophenolate(cellcept)
Cuprimine (penicillamine)
Corticosteroids
Aminosalicylates (e.g. sulfasalazine, azulfidine, mesalamine)
_____________________________
Please Document Dates of therapies for medications selected:
_____________________________
Please document any clinical contraindications to these medications:
Has the patient had a trial, failure or contraindication to any of the following medications? (Please list dosage and/or contraindication)
Dosage / Contraindication
®
Enbrel
Yes
No
®
Humira
Yes
No
®
Remicaid
Yes
No
®
Orencia
Yes
No
®
Kineret
Yes
No
®
Simponi
Yes
No
®
Cimzia
Yes
No
®
Actemra
Yes
No
®
Stelara
Yes
No
Other
Please list...
Yes
Continuation of Therapy
Yes
No
Has the patient utilized the medication in the past 45 days?
Yes
No
Has the patient had documented clinical improvement from ongoing therapy?
(Please document dose reduction or reason for high dose [if applicable])
*If the above information is not available, please attach the patient’s chart notes documenting clinical improvement.
*If you have any questions regarding your patient’s plan drug limits you may call us at: 1-800-711-4555
.
For UHC members: Your patient’s prescription benefit requires that we review certain requests for coverage with the prescriber. You have prescribed a
medication for your patient that requires Prior Authorization before benefit coverage can be provided. Please complete the following questions then fax this
form to the toll free number listed below. Upon receipt of the completed form, prescription benefit coverage will be determined based on the plan’s rules
his electronic fax transmission, including any attachments contains information from OptumRx that may be confidential and/or privileged. The information
T
contained in this facsimile is intended to be for the sole use of the individual(s) or entity named above. If you are not the intended recipient, be aware that
any disclosure, copying, distribution or use of the contents of this information is strictly prohibited by law and will be vigorously prosecuted. If you have
received this electronic fax transmission in error, please notify the sender immediately and return the document(s) by mail to OptumRx Privacy Office, 2300
Main
St.,
M/S
CA134-0501,
Irvine,
CA
92614
Enbrel-Humira-Kineret-Orencia-Remicade-Simponi-Cimzia-Actemra-
Stelara_2012June.doc